Predmenstrual'nyy sindrom: osobennosti diagnostiki i lecheniya


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article discusses the modern concept of the complex pathogenesis of premenstrual syndrome (PMS) and approaches to its treatment. The diversity of clinical manifestations of PMS that causes a variety of therapeutic agents used is emphasized. Numerous studies suggests the great importance of magnesium deficiency as a factor of the development of PMS. This indicates the necessity of magnesium preparations (in particular, magnesium orotate) for all types of treatment of PMS.

全文:

受限制的访问

参考

  1. Буданов П.В. Лечение предменструального синдрома: современные представления и перспективы. Трудный пациент. 2012; 2-3.
  2. Громова О.А., Лиманова О.А., Торшин И.Ю. Систематический анализ фундаментальных и клинических исследований, как обоснование необходимости совместного использования эстрогенсодержащих препаратов с препаратами магния и пиридоксина. Акушерство, гинекология и репродукция. 2013; 3: 35-50.
  3. Громова О.А., Торшин И.Ю., Грустливая У.Е., Калачева А.Г., Гришина Т.Р. Дефицит магния и судороги мышц: возможности профилактики и терапии Магнеротом (клинико-фармакологическая лекция). Фарматека. 2012; 14: 34-8.
  4. Кузнецова И.В., Коновалов В.А. Пролонгированный прием комбинированного орального контрацептива, содержащего дроспиренон, в лечении предменструального синдрома. Проблемы репродукции. 2008; 4: 28-31.
  5. Прилепская В.Н., Межевитинова Е.А., Назарова Н.М. и др. Лечебные возможности современной гормональной контрацепции. Акцент на дроспиренонсодержащее соединение с новым режимом дозирования. Гинекология. 2012; 1: 42-5.
  6. Ткаченко Л.В., Атагаджиева М.С., Курушина О.В. Качество жизни женщин, страдающих предменструальным синдромом. Проблемы социальной гигиены и история медицины. 2010; 2: 13-6.
  7. ACOG Practice Bulletin: No 15: Premenstrual syndrome. Obstet. Gynecol. 2000; 95: 1-9.
  8. Blum M., Kitai E., Ariel Y., Schnierer M., Bograd H. Oral contraceptive lowers serum magnesium. Harefuah. 1991; 121(10): 363-64.
  9. Brown J., O'Brien P.M., Marjoribanks J., Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst. Rev. 2009; 2: CD001396.
  10. Case A.M., Reid R.L., Effects of the menstrual cycle on medical conditions. Arch. Intern. Med. 1998; 158: 1405-12.
  11. Coffee A.L., Kuehl T.J., Willis S., Sulak P.J. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am. J. Obstet. Gynecol. 2006; 156: 1311-19.
  12. Facchinetti F., Borella P., Sances G., et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet. Gynecol. 1991; 78(2): 177-81.
  13. Fathizadeh N., Ebrahimi E., Valiani M., Tavakoli N., Yar M.H. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran. J. Nurs. Midwifery Res. 2010; 15(Suppl 1): 401-5.
  14. Frank R.T. The hormonal causes of premenstrual tension. Arch. Neurol. Psychiatry 1931; 26: 1053-57.
  15. Freeman E.W. Therapeutic management of premenstrual syndrome. Expert Opin. Pharmacother. 2010; 11(17): 2879-89.
  16. Freeman E.W., Rickels K., Sondheimer S.J., Polansky M. A double blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA. 1995; 274: 51-7.
  17. Grady-Weliky T.A. Clinical practice. Premenstrual dysphoric disorder. N. Engl. J. Med. 2003; 348: 433-38.
  18. Hahn P.M., Van Vugt D.A., Reid R.L. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 1995; 20: 193-209.
  19. Henshaw C., Foreman D., Belcher J., et al. Can one induce premenstrual symptomatology in women with prior hysterectomy and bilateral oopherectomy? J. Psychosom. Obstet. Gynaecol. 1996; 17: 21.
  20. Joffe H., Petrillo L.F., Viguera A.C., et al. Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report. J. Clin. Psychiatry. 2007; 68: 1954-62.
  21. Kadian S., O'Brien S. Classification of premenstrual disorders. Menopause Int. 2012; 18: 43-7.
  22. Landen M., Eriksson O., Sundblad C., et al. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Psychopharmacology. 2001; 155: 292-798.
  23. Leminen H., Paavonen J. PMS and PMDD. Duodecim. 2013; 129(17): 1756-63.
  24. Lopez L.M., Kaptein A.A., Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst. Rev. 2012; 2: CD006586.
  25. O'Brien P.M., Backstrom T., Brown C., et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch. Womens Ment. Health 2011; 14: 13-21.
  26. O'Brien S., Rapkin A., Dennerstein L., Nevatte T. Diagnosis and management of premenstrual disorders. BMJ. 2011; 342: d2994.
  27. Oelkers W., Helmerhorst F.M., Wuttke W. Effect of an oral contraceptives containing drospirenone on the rennin-angiotensin-aldosterone system in healthy female volunteers. Gynecol. Endocrinol. 2006; 14: 204-13.
  28. Oelkers W. Drospirenone, a progestogen with antmineralocorticoid properties: a short review. Mol. Cell Endocrinol. 2004; 17 (1-2): 255-61.
  29. Olatunbosun D.A., Adeniyi F.A., Adadevoh B.K. Effect of oral contraceptives on serum magnesium levels. Int. J. Fertil. 1974; 19 (4): 224-26.
  30. Rapkin A.J., Chang L.C., Reading A.E. Comparison of retrospective and prospective assessment of premenstrual symptoms. Psychol. Rep. 1988; 62: 55-60.
  31. Rapkin A.J., Winer S.A. The pharmacologic management of premenstrual dysphoric disorder. Expert Opin. Pharmacother. 2008; 9: 1-17.
  32. Schmidt P.J., Neiman L.K., Danaceau M.A., et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 1998; 338: 209-16.
  33. Sherwood R.A., Rocks B.F., Stewart A., Saxton R.S. Magnesium and the premenstrual syndrome. Ann. Clin. Biochem. 1986; 23(Pt 6): 667-70.
  34. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas. 2008; 61(1-2): 151-57.
  35. Steiner M., Pearlstein T., Cohen L.S., et al. Expert guidelines for the treatment of severe PMS, PMDD, and co morbidities: the role of SSRIs. J. Womens Health. (Larchmt) 2006; 15: 57-69.
  36. The American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000: 717-18.
  37. Tuccori M., Testi A., Antonioli L., et al. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/nor adrenergic antidepressants during pregnancy: a review. Clin. Ther. 2009; 31: 1426-53.
  38. Verma R.K., Chellappan D.K., Pandey A.K. Review on treatment of premenstrual syndrome: from conventional to alternative approach. J. Basic. Clin. Physiol. Pharmacol. 2014. Mar 12.
  39. Walker A.F., De Souza M.C., Vickers M.F., et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J. Womens Health. 1998; 7(9): 1157-65.
  40. Wang M., Hammarback S., Lindhe B.A., Backström T. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet. Gynecol. Scand. 1995; 74: 803-8.
  41. Wichianpitaya J., Taneepanichskul S. A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms. Obstet. Gynecol. Int. 2013; 2013: 487143. doi: 10.1155/2013/487143. Epub 2013 Feb 20.
  42. World Health Organization (WHO). International Classification of Diseases. 10th edn. Geneva: WHO, 1996.
  43. Wyatt K., Dimmock P., Jones P., Obhrai M., O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ. 2001; 323: 776.
  44. Wyatt K.M., Dimmock P.W., Ismail K.M., O'Brien P.M.S. The effectiveness of GnRHa with and without "add-back" therapy in treating premenstrual syndrome: a meta-analysis. Br. J. Obstet. Gynaecol. 2004; 111: 585-93.
  45. Wyatt K.M., Dimmock P.W., O'Brien P.M.S. Efficacy of vitamin B6 in the treatment of premenstrual syndrome: a systematic review. BMJ. 1999; 318: 1375.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##